Prosight Management as of March 31, 2021
Portfolio Holdings for Prosight Management
Prosight Management holds 37 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 12.3 | $15M | 600k | 25.12 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.7 | $8.2M | 38k | 214.89 | |
| Encompass Health Corp (EHC) | 6.7 | $8.2M | 100k | 81.90 | |
| Arena Pharmaceuticals Com New | 6.0 | $7.3M | 106k | 69.39 | |
| Cue Biopharma (CUE) | 5.6 | $6.8M | 557k | 12.20 | |
| Bristol Myers Squibb (BMY) | 4.9 | $6.0M | 96k | 63.13 | |
| Albireo Pharma | 4.9 | $6.0M | 170k | 35.25 | |
| Aldeyra Therapeutics (ALDX) | 4.6 | $5.6M | 473k | 11.88 | |
| Galapagos Nv Spon Adr (GLPG) | 4.2 | $5.1M | 66k | 77.09 | |
| Aurinia Pharmaceuticals (AUPH) | 3.8 | $4.7M | 361k | 12.98 | |
| Kezar Life Sciences | 3.7 | $4.5M | 750k | 5.96 | |
| Meiragtx Holdings (MGTX) | 3.4 | $4.2M | 292k | 14.43 | |
| Zogenix Com New | 3.1 | $3.8M | 195k | 19.52 | |
| Zimmer Holdings (ZBH) | 2.8 | $3.4M | 21k | 160.07 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 2.4 | $3.0M | 450k | 6.61 | |
| Oscar Health Cl A (OSCR) | 2.4 | $2.9M | 107k | 26.88 | |
| Cellectis S A Spon Ads (CLLS) | 2.3 | $2.8M | 138k | 20.21 | |
| Inovalon Hldgs Com Cl A | 2.0 | $2.4M | 85k | 28.78 | |
| Medtronic SHS (MDT) | 1.9 | $2.4M | 20k | 118.13 | |
| UnitedHealth (UNH) | 1.8 | $2.2M | 6.0k | 372.00 | |
| Cara Therapeutics | 1.8 | $2.2M | 100k | 21.71 | |
| Metacrine Ord | 1.5 | $1.9M | 305k | 6.20 | |
| Solid Biosciences | 1.4 | $1.8M | 320k | 5.53 | |
| LHC | 1.4 | $1.7M | 8.8k | 191.16 | |
| Akumin | 1.3 | $1.6M | 429k | 3.70 | |
| Beam Therapeutics (BEAM) | 1.1 | $1.4M | 17k | 80.06 | |
| Alexion Pharmaceuticals | 1.1 | $1.3M | 8.7k | 152.91 | |
| Oncorus | 0.8 | $986k | 71k | 13.93 | |
| Aptose Biosciences Com New | 0.7 | $896k | 150k | 5.97 | |
| Adma Biologics (ADMA) | 0.7 | $876k | 498k | 1.76 | |
| Exicure | 0.5 | $601k | 276k | 2.18 | |
| Sio Gene Therapies Common | 0.4 | $537k | 206k | 2.61 | |
| Baxter International (BAX) | 0.4 | $489k | 5.8k | 84.31 | |
| Odonate Therapeutics Ord | 0.3 | $402k | 118k | 3.42 | |
| Morphic Hldg (MORF) | 0.3 | $329k | 5.2k | 63.24 | |
| Organogenesis Hldgs (ORGO) | 0.2 | $278k | 15k | 18.25 | |
| Assembly Biosciences | 0.2 | $260k | 57k | 4.60 |
